Centum Electronics Ltd
Q2 FY23 Earnings Call Analysis
Industrial Manufacturing
fundraise: No informationcapex: No informationrevenue: Category 2margin: Category 1orderbook: No information
💰fundraise
Any current/future new fundraising through debt or equity?
- There is no mention of any current or future plans for fundraising through debt or equity in the provided transcript.
- The company has noted an increase in finance costs compared to the last year but manages them reasonably without indicating new borrowing.
- The focus appears to be on improving profitability and reducing costs, especially in subsidiaries, rather than raising new capital.
- No specific comments on equity issuance or debt raising were made during the call.
🏗️capex
Any current/future capex/capital investment/strategic investment?
- The transcript does not explicitly mention any specific current or future capex or capital investments.
- Strategic focus is on operational improvements such as margin optimization in the French subsidiary through cost reduction and execution efficiency.
- There is a shift in the Canadian subsidiary with transfer of manufacturing to India to reduce costs.
- The company is making strategic moves to increase onshore-offshore mix in engineering services, which is a gradual two-to-three-year journey.
- Growth levers include expansion into automotive, clean tech, electric mobility, and industrial electronics, with new customer ramp-ups.
- The focus is on bidding for bigger projects supported by the combined strength of Indian and French entities.
- Investment in technology upgrades such as Industry 4.0, automation, and digitalization is underway to improve process efficiencies, particularly in EMS operations.
No explicit details on fixed asset capex or new strategic capital investments were shared in the provided pages.
📊revenue
Future growth expectations in sales/revenue/volumes?
- Centum expects overall consolidated revenue growth around 20% CAGR over the next 2-3 years.
- EMS business is projected to grow aggressively, driving part of this growth beyond the 20% overall target.
- Growth levers include expansion in automotive (electric vehicles), industrial electronics, clean tech, and medical devices.
- French subsidiary aims to improve margins first before pushing significant growth, with some reasonable growth expected this year.
- Build-to-spec (BTS) and engineering R&D (ER&D) segments are expected to contribute to growth via new order intake and project wins.
- Indian market remains a primary focus, with selective participation in global programs.
- Pipeline for domestic defense, space, railways, and electric mobility sectors is strong, supporting sustained volume growth.
- Order book remains steady (~1540 crore) with good opportunities, suggesting stable execution and revenue visibility.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- Overall revenue growth target: ~20% medium-term growth (Nikhil Mallavarapu).
- EMS segment expected to see aggressive growth, as it forms ~39% of revenues (K S Desikan/Nikhil).
- Engineering R&D (ER&D) business growth expected to be low single digits, focus on improving profitability (Nikhil/Mallavarapu).
- French subsidiary focus initially on margin improvement (targeting 7-8% EBITDA in FY24) before significant growth; margin target 10%+ longer term (Nikhil Mallavarapu/K S Desikan).
- Consolidated EBITDA margin target: moving up to 13-15% over 2-3 years (Nikhil Mallavarapu).
- Subsidiaries (France, Canada) expected to break even/grow profitability in second half FY24; cost reduction and onshore-offshore leverage key (K S Desikan).
- New growth drivers: electric mobility, clean tech, industrial electronics, defense, and passenger information systems (Nikhil Mallavarapu).
- Earnings improvement expected from operational efficiencies, cost controls, and larger project wins (K S Desikan).
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- The order book at the end of Q1 FY24 stands steady at approximately INR 1540-1542 crores, similar to March 2023 levels.
- Outlook for the order book is strong with a robust opportunity pipeline.
- Execution periods vary: EMS orders typically 12-15 months, Build to Spec (BTS) orders 2 to 2.5 years, and Engineering R&D (ER&D) orders 8-12 months.
- Order inflows in Q1 were roughly equivalent to revenue, keeping the order book flat.
- There are multiple ongoing opportunities in EMS and BTS segments, with significant bids in Indian metro projects and existing global OEM engagements.
- Strong traction noted in electric mobility, passenger information systems, and indigenization of defense and space sectors.
- The company expects order book growth with 20% medium-term revenue growth guidance.
